Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Eur J Pharm Biopharm. 2018 Sep;130:207-213. doi: 10.1016/j.ejpb.2018.07.003. Epub 2018 Jul 3.

Introduction to the OrBiTo decision tree to select the most appropriate in vitro methodology for release testing of solid oral dosage forms during development.

Author information

1
Institute of Pharmaceutical Technology, Goethe University Frankfurt, Frankfurt am Main, Germany.
2
Product Development and Supply, GlaxoSmithKline R&D, Ware, UK.
3
Drug Delivery and Disposition, KU Leuven, Leuven, Belgium.
4
Drug Product Design, Pfizer PGRD, Sandwich, UK.
5
Department of Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden.
6
Institute of Pharmaceutical Technology, Goethe University Frankfurt, Frankfurt am Main, Germany. Electronic address: Dressman@em.uni-frankfurt.de.

Abstract

The EU research initiative OrBiTo (oral biopharmaceutics tools) involving partners from academia, pharmaceutical industry, small medium enterprises and a regulatory agency was launched with the goal of improving tools to predict the absorption of drugs in humans and thereby accelerating the formulation development process. The OrBiTo project was divided into four work packages (WP), with WP2 focusing on characterization of drug formulations. The present work introduces the OrBiTo WP2 Decision Tree, which is designed to assist the investigator in choosing the most appropriate in vitro methods for optimizing the oral formulation design and development process. The WP2 Decision Tree consists of four stages to guide the investigator. At the first stage, the investigator is asked to choose the formulation type of interest. At the second stage, the investigator is asked to identify which type of equipment (compendial/modified/noncompendial) is preferred/available. At the third stage, characteristics of the active pharmaceutical ingredient (API) are evaluated and in the fourth stage of the decision tree, suitable experimental protocols are recommended. A link to the living Decision Tree document is provided, and we now invite the pharmaceutical sciences community to apply it to current research and development projects and offer suggestions for improvement and expansion.

KEYWORDS:

Biopharmaceutics classification system (BCS); Decision tree; Dissolution; Formulation; Oral absorption; PBPK

PMID:
30064698
DOI:
10.1016/j.ejpb.2018.07.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center